Targeted Medical Pharma Net Profit Margin 2014-2015 | TRGM

Targeted Medical Pharma net profit margin from 2014 to 2015. Net profit margin can be defined as net Income as a portion of total sales revenue.
Targeted Medical Pharma Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Targeted Medical Pharma, Inc. is a biotechnology company. It develops amino acid based medical foods for the treatment of chronic disease, including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep and cognitive disorders. The Company also develops a line of dietary supplements designed to support health and wellness. It is also developing nutrient-based systems for oral stimulation of progenitor stem cells that differentiate into neurons, red blood cells, pituitary hormones including IGF-I. Targeted Medical Pharma, Inc. is based in Los Angeles, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $18.684B 6.68
Dr Reddy's Laboratories (RDY) India $12.031B 21.83
BridgeBio Pharma (BBIO) United States $8.691B 0.00
Bausch Health Cos (BHC) Canada $2.409B 1.74
Supernus Pharmaceuticals (SUPN) United States $1.829B 14.85
Amphastar Pharmaceuticals (AMPH) United States $1.006B 6.76
Personalis (PSNL) United States $0.568B 0.00
Taysha Gene Therapies (TSHA) United States $0.565B 0.00
Assembly Biosciences (ASMB) United States $0.143B 0.00
Sol-Gel Technologies (SLGL) Israel $0.026B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00